(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid has been researched along with Seizures in 1 studies
(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid: a GABA-C receptor antagonist; structure in first source
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flores-Gracia, C | 1 |
| Nuche-Bricaire, A | 1 |
| Crespo-Ramírez, M | 1 |
| Miledi, R | 1 |
| Fuxe, K | 1 |
| Pérez de la Mora, M | 1 |
1 other study available for (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid and Seizures
| Article | Year |
|---|---|
GABA(A) ρ receptor mechanisms in the rat amygdala and its role in the modulation of fear and anxiety.
Topics: Amygdala; Animals; Anxiety; Behavior, Animal; Bicuculline; Corticosterone; Dose-Response Relationshi | 2010 |